Skip to content

Worldwide Sarcoidosis Research Study

Worldwide Sarcoidosis Research Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01610843
Acronym
WISE
Enrollment
2200
Registered
2012-06-04
Start date
2011-12-31
Completion date
2025-10-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Keywords

Sarcoidosis, WISE, Sarcoid Study, Worldwide Sarcoidosis Research Study

Brief summary

The aim of this study is to collect information about the clinical course and characteristics of sarcoidosis patients around the world through web-based surveys. Recruitment is directed at and driven by patients in the sarcoidosis community. This will allow the the investigators to study sarcoidosis patients across all demographic, geographic, and socioeconomic boundaries, not just patients seen at large research centers. The investigators believe this study can give investigators a broader and less biased view of sarcoidosis. The investigators would also like to collect genetic samples on this population to assess genetic variance in different phenotypes. The information for the study would be provided through a web based survey system that can be accessed by patients or physicians of patients from any computer with Internet access. This system would collect clinical information in sufficient detail so that the phenotype of individual patients can be evaluated. Upon agreeing to participate in further research studies through the website, subjects will also have the opportunity to provide a DNA sample.

Interventions

OTHERSurvey

Longitudinal surveys

Sponsors

National Center for Research Resources (NCRR)
CollaboratorNIH
Alicia Gerke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Sarcoidosis * Access to a computer with Internet

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Define and characterize sarcoidosis phenotypes and methods of careAnticipated by 2017To give a broader and less biased view of sarcoidosis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026